tiprankstipranks
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
MDMA
PharmAla Biotech Holdings, Inc.
RESEARCH TOOLSreports
Want to see TSE:MDMA full AI Analyst Report?

PharmAla Biotech Holdings, Inc. (MDMA) Revenue

64 Followers
StatisticsMarket CapRevenue

PharmAla Biotech Holdings, Inc. Revenue

PharmAla Biotech Holdings, Inc. had a revenue of 280.58K in the quarter ending Feb 28, 2026, with 4.94%. This bring the company's revenue in the last twelve months to 889.57K, Decreased 46.92%. In the fiscal year ending Nov 30, 2025, PharmAla Biotech Holdings, Inc. had annual revenue of 605.50K with -41.51% growth.
Revenue (ttm)
889.57K
Revenue Growth
125.00%
P/S Ratio
25.18
Revenue/Employee
―
Employees
―
Market Cap
C$15.24M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Nov 30, 2025
605.50K-429.80K-41.51%
Nov 30, 2024
1.04M503.29K+94.60%
Nov 30, 2023
532.00K453.93K+581.44%
Nov 30, 2022
78.07K―+∞%
Aug 31, 2021
―――